Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia

Among women diagnosed with stage I–IIIa, node-negative, hormone receptor (HR)-positive breast cancer (BC), Oncotype DX recurrence scores (ODX RS) inform chemotherapy treatment decisions. Differences in recurrence scores or testing may contribute to racial disparities in BC mortality among women with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:NPJ Breast Cancer
Päätekijät: Collin, Lindsay J., Yan, Ming, Jiang, Renjian, Ward, Kevin C., Crawford, Brittany, Torres, Mylin A., Gogineni, Keerthi, Subhedar, Preeti D., Puvanesarajah, Samantha, Gaudet, Mia M., McCullough, Lauren E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763428/
https://ncbi.nlm.nih.gov/pubmed/31583272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0129-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia